Skip to main content
Porto

Main navigation

  • Home
  • PMMNG Meetings
    • PMMNG Monthly Meetings
    • Steering Committee Meetings
  • Myeloma Events
  • Our Members
  • Miles for Myeloma 5K
  • Diversity & Inclusion
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Previous Meetings

  • October 2025 PMMNG Meeting -Special CAR-T Panel Discussion
  • September 2025 PMMNG Meeting - "HealthTree's Cure Hub" by Todd Foster and Open Discussion
  • August 2025 -- No PMMNG Meeting
  • July 2025 PMMNG Meeting - "Interpreting Test Results and Living with Multiple Myeloma" by Grace Allison and Open Discussion
  • June 2025 PMMNG Meeting - SparkCures Overview by Brian McMahon
  • May 2025 -- No PMMNG Meeting (IMF Patient & Family Seminar Instead)
  • April 2025 PMMNG Meeting - Bone Health in Multiple Myeloma by Matthew Drake, MD, PhD
  • March 2025 PMMNG Meeting - Update from ASH 2024 by Dr. Dan Vogl
  • February 2025 PMMNG Meeting: Open Discussion
  • January 2025 PMMNG Meeting: "Living Your Best Life: Survivorship, Illness Prevention & Health Maintenance" Presented by Teresa Miceli, RN BSN OCN
  • December 2024 PMMNG Meeting: Annual Year End Celebration
  • November 2024 PMMNG Meeting: Annual Health Insurance Navigation Session

The February 11, 2017 program will be a presentation of highlights about Multiple Myeloma research and treatment from the recent annual ASH (American of Society of Hematology) meeting. Our speaker will be  Adam D. Cohen, MD, Assistant Professor and Director of Myeloma Immunotherapy at the Abramson Cancer Center of the U of Pennsylvania. He will also provide a general overview of how immunotherapy is being used in treating myeloma. Lunch will be provided by Takeda Pharmaceuticals.

Dr. Cohen's slides

Tags
meeting
pmmng
ash
research
treatment
upenn